Graves’ disease is an autoimmune disorder characterised by the production of thyroid-stimulating hormone receptor antibodies (TRAb), which activate thyroid-stimulating hormone (TSH) receptors on thyroid follicular cells, leading to excessive synthesis and secretion of thyroxine (T4) and triiodothyronine (T3) [1]. Here, TSHR is linked to Autoimmunity.